Skip to NavigationSkip to content

News

Acasti Pharma’s shares plunged by as much as 67% this week as its drug CaPre failed to meet its primary endpoint. The drug was treating severe...
Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop it into a treatment for...
The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces 'bad' cholesterol.
Janssen’s Zytiga has just been approved by the Scottish Medicines Consortium, meaning that male patients on the NHS in Scotland will now be able to...
The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns.
Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development of therapies for...
The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has registered cases against 200...
AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial.
Bayer AG has partnered with Exscientia to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology.
Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches